# management (video feeds) — RSS Amplifier Recent posts from the 12 feeds in the RSS Amplifier directory that cover management. Page: Feed: --- ## [AKT Inhibition in Prostate Cancer — Microlearning Activity 2: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium](https://videopodcast.researchtopractice.com/akt-inhibition-in-prostate-cancer-microlearning-activity-2-proceedings-from-a-session-held-adjunct-to-the-2026-asco-gu-cancers-symposium) _2026-08-22 · Research To Practice | Oncology Videos_ Featuring perspectives from Dr Karim Fizazi, Dr Daniel George and Dr Elisabeth I Heath, moderated by Dr Heath, including the following topics: Treatment approach for AKT-mutated prostate cancer — Question from Neeraj Agarwal, MD, FASCO (0:00) Case: A man in his late 60s with de novo metastatic hormone-sensitive prostate cancer with widespread skeletal metastases and PTEN loss on next-generation… [Listen](https://traffic.libsyn.com/secure/researchtopractice/ASCO_GU_Prostate_2-27-26_Micro_Issue_2_V2FC_480.mp4?dest-id=1103750) ## [AKT Inhibition in Prostate Cancer — Microlearning Activity 1: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium](https://videopodcast.researchtopractice.com/akt-inhibition-in-prostate-cancer-microlearning-activity-1-proceedings-from-a-session-held-adjunct-to-the-2026-asco-gu-cancers-symposium) _2026-08-21 · Research To Practice | Oncology Videos_ Featuring perspectives from Dr Karim Fizazi, Dr Daniel George and Dr Elisabeth I Heath, moderated by Dr Heath, including the following topics: Role of PTEN deficiency in tumorigenesis of prostate cancer and optimal approach to PTEN assessment — Question from Neeraj Agarwal, MD, FASCO (0:00) Case: A man in his late 60s with a history of nonmetastatic hormone-sensitive prostate cancer (HSPC) that… [Listen](https://traffic.libsyn.com/secure/researchtopractice/ASCO_GU_Prostate_2-27-26_Micro_Issue_1_V2FC_480.mp4?dest-id=1103750) ## [Gastroesophageal Cancers — Year in Review Series on Relevant New Datasets and Advances](https://videopodcast.researchtopractice.com/gastroesophageal-cancers-year-in-review-series-on-relevant-new-datasets-and-advances) _2026-08-20 · Research To Practice | Oncology Videos_ Featuring perspectives from Dr David H Ilson and Dr Kohei Shitara, including the following topics: Introduction (0:00) Biomarker Evaluation in Localized and Metastatic Disease (1:49) Role of Immune Checkpoint Inhibitors in the Management of Gastroesophageal Cancers — Dr Ilson (7:37) Other Available Therapeutic Approaches — Dr Shitara (33:22) CME information and select publications [Listen](https://traffic.libsyn.com/secure/researchtopractice/YiR_GE_6-23-26_V1_480p.mp4?dest-id=1103750) ## [Gastroesophageal Cancers | David H Ilson, MD, PhD](https://videopodcast.researchtopractice.com/gastroesophageal-cancers-david-h-ilson-md-phd) _2026-08-19 · Research To Practice | Oncology Videos_ Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Gastroesophageal Cancers | Faculty Presentation 1: Role of Immune Checkpoint Inhibitors in the Management of Gastroesophageal Cancers — David H Ilson, MD, PhD CME information and select publications [Listen](https://traffic.libsyn.com/secure/researchtopractice/Ilson_6-16-26_V1_1FC_480.mp4?dest-id=1103750) ## [Gastroesophageal Cancers | Kohei Shitara, MD](https://videopodcast.researchtopractice.com/gastroesophageal-cancers-kohei-shitara-md) _2026-08-19 · Research To Practice | Oncology Videos_ Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Gastroesophageal Cancers | Faculty Presentation 2: Other Available Therapeutic Approaches — Kohei Shitara, MD CME information and select publications [Listen](https://traffic.libsyn.com/secure/researchtopractice/Shitara_6-15-26_V1_TW_480p.mp4?dest-id=1103750) ## [Genitourinary Cancers — Reviewing Key Presentations from the 2026 ASCO Annual Meeting](https://videopodcast.researchtopractice.com/genitourinary-cancers-reviewing-key-presentations-from-the-2026-asco-annual-meeting) _2026-08-19 · Research To Practice | Oncology Videos_ Featuring perspectives from Dr Rahul Aggarwal, Dr Matthew D Galsky and Dr Tian Zhang, including the following topics: Introduction: Welcome GU Oncology Fellows! (0:00) Prostate Cancer — Dr Aggarwal (12:48) Urothelial Bladder Cancer — Dr Galsky (45:01) Renal Cell Carcinoma — Dr Zhang (1:10:52) CME information and select publications [Listen](https://traffic.libsyn.com/secure/researchtopractice/Post_ASCO_GU_7-16-26_V1_480p.mp4?dest-id=1103750) ## [For Oncology Nurses: Oral Selective Estrogen Receptor Degraders in Breast Cancer — Proceedings from the 2026 Annual ONS Congress](https://videopodcast.researchtopractice.com/for-oncology-nurses-oral-selective-estrogen-receptor-degraders-in-breast-cancer-proceedings-from-the-2026-annual-ons-congress) _2026-08-18 · Research To Practice | Oncology Videos_ Featuring perspectives from Ms Blanca Ledezma, Dr Marissa Marti-Smith, Dr Heather McArthur and Dr Ruth M O'Regan, moderated by Dr McArthur, including the following topics: · Introduction (0:00) · Current Clinical Role of Oral Selective Estrogen Receptor Degraders (SERDs) in HR-Positive Metastatic Breast Cancer (3:37) · Practical Considerations with Oral SERDs (15:43) · Potential Role of… [Listen](https://traffic.libsyn.com/secure/researchtopractice/11_ONS_Oral_SERDs_5-16-26_V1_480p.mp4?dest-id=1103750) ## [Metastatic Bladder Cancer — Rapid Case Review Issue 6](https://videopodcast.researchtopractice.com/metastatic-bladder-cancer-rapid-case-review-issue-6) _2026-08-18 · Research To Practice | Oncology Videos_ Featuring perspectives from Prof Yohann Loriot, including the following topics: Case: A man in his early 80s with metastatic urothelial bladder cancer (mUBC) receives enfortumab vedotin (EV)/pembrolizumab but experiences immune-related adverse events requiring steroids and then develops neuropathy due to EV — Nazli Dizman, MD (0:00) Case: A man in his early 70s with diabetes who received adjuvant… [Listen](https://traffic.libsyn.com/secure/researchtopractice/Loriot_6-16-26_Issue_6_V3FC_480.mp4?dest-id=1103750) ## [Why Does Google Pay Him $2M A Year?](https://nathanlatkathetop.libsyn.com/why-does-google-pay-him-2m-a-year) _2026-08-18 · Top Founders_ Stéphane Donzé has bootstrapped AODocs and Talarian to a combined $60m in 2026 revenue without raising capital. His top three customers each pay more than $2m per year, including Google, which pays him millions annually to control the documents behind its data center builds. He funded fourteen years of R&D off a cloud consulting business, never burned more than $200k in a month, and has fielded… [Listen](https://podtrac.com/pts/redirect.mp3/traffic.libsyn.com/secure/nathanlatkathetop/AO_DOcs_Final.mp4?dest-id=284781) ## [Metastatic Bladder Cancer — Rapid Case Review Issue 5](https://videopodcast.researchtopractice.com/metastatic-bladder-cancer-rapid-case-review-issue-5) _2026-08-17 · Research To Practice | Oncology Videos_ Featuring perspectives from Prof Yohann Loriot, including the following topics: Case: A man in his early 80s with Parkinson disease and a history of renal transplant presents with metastatic urothelial bladder cancer (UBC) and receives first-line enfortumab vedotin (EV) with a good response but develops neuropathy and skin toxicity — Jacqueline T Brown, MD (0:00) Case: A man in his early 90s with… [Listen](https://traffic.libsyn.com/secure/researchtopractice/Loriot_6-16-26_Issue_5_V3FC_480.mp4?dest-id=1103750) ## [Realtime AI Arbitrage Terminal (Sponsored)](https://crawlproof.com/a/cuehNQErqcSw) _2026-08-17 · **Sponsored**_ Realtime auto-trading across exchanges with scored setups, backtesting, and risk controls. ## [Multiple Myeloma — Year in Review Series on Relevant New Datasets and Advances](https://videopodcast.researchtopractice.com/multiple-myeloma-year-in-review-series-on-relevant-new-datasets-and-advances-1) _2026-08-17 · Research To Practice | Oncology Videos_ Featuring perspectives from Dr Amrita Krishnan and Dr Robert Z Orlowski, including the following topics: Introduction (00:00) Up-Front Progression-Free Survival for Standard-Risk Disease — 2006, 2016 (1:47) Current and Emerging Therapeutic Approaches — Dr Orlowski (10:34) Chimeric Antigen Receptor T-Cell Therapy, Bispecific Antibodies and Antibody-Drug Conjugates — Dr Krishnan (27:15) ASCO and EHA… [Listen](https://traffic.libsyn.com/secure/researchtopractice/YiR_MM_6-25-26_V1_480p.mp4?dest-id=1103750) ## [Multiple Myeloma | Robert Z Orlowski, MD, PhD](https://videopodcast.researchtopractice.com/multiple-myeloma-robert-z-orlowski-md-phd) _2026-08-17 · Research To Practice | Oncology Videos_ Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Multiple Myeloma | Faculty Presentation 1: Current and Emerging Therapeutic Approaches for Multiple Myeloma — Robert Z Orlowski, MD, PhD CME information and select publications [Listen](https://traffic.libsyn.com/secure/researchtopractice/Orlowski_6-22-26_V1TW_1_480p.mp4?dest-id=1103750) ## [Multiple Myeloma | Amrita Krishnan, MD](https://videopodcast.researchtopractice.com/multiple-myeloma-amrita-krishnan-md) _2026-08-17 · Research To Practice | Oncology Videos_ Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Multiple Myeloma | Faculty Presentation 2: Chimeric Antigen Receptor T ‑ Cell Therapy, Bispecific Antibodies and Antibody ‑ Drug Conjugates — Amrita Krishnan, MD CME information and select publications [Listen](https://traffic.libsyn.com/secure/researchtopractice/Krishnan_6-15-26_V1TW_1_480p.mp4?dest-id=1103750) ## [Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Microlearning Activity 2: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium](https://videopodcast.researchtopractice.com/non-muscle-invasive-and-muscle-invasive-bladder-cancer-microlearning-activity-2-proceedings-from-a-session-held-adjunct-to-the-2026-asco-gu-cancers-symposium) _2026-08-15 · Research To Practice | Oncology Videos_ Featuring perspectives from Dr Terence Friedlander, Dr Matthew Galsky, Dr Shilpa Gupta and Prof Andrea Necchi, moderated by Dr Friedlander, including the following topics: Case: A woman in her late 60s with T3N0 upper tract urothelial carcinoma that was resected has no evidence of disease on imaging, receives negative circulating tumor DNA results and elects observation instead of adjuvant… [Listen](https://traffic.libsyn.com/secure/researchtopractice/ASCO_GU_Bladder_2-26-26_ML_V3FC_Issue_2_480.mp4?dest-id=1103750) ## [Patch-Apokalypse: Wenn IT-Teams den Angreifern hinterherlaufen](https://www.all-about-security.de/podcast/patch-apokalypse-wenn-it-teams-den-angreifern-hinterherlaufen/) _2026-08-15 · Unter4Ohren_ Patch-Apokalypse: Wenn IT-Teams den Angreifern hinterherlaufen [Listen](https://www.all-about-security.de/podlove/file/6574/s/feed/c/mp4/patch-apokalypse-wenn-it-teams-den-angreifern-hinterherlaufen.mp4) ## [Raj Chovatiya, MD, PhD, MSCI - In Your Hands: A Case-Based Approach to Treating Moderate-to-Severe Chronic Hand Eczema](https://peervoice.com/MSG860) _2026-08-14 · PeerVoice Endocrinology & Metabolic Disorders Video_ Raj Chovatiya, MD, PhD, MSCI - In Your Hands: A Case-Based Approach to Treating Moderate-to-Severe Chronic Hand Eczema [Listen](https://peervoice.com/540200056MSG.m4v?ProjectNumber=540200056&Promocode=862&AudienceID=PV) ## [Luis Querol, MD, PhD - CIDP at a Crossroads: Addressing the Burden of Suboptimal Care and the Need for Therapeutic Advancement](https://peervoice.com/RZR860) _2026-08-14 · PeerVoice Brain & Behaviour Video_ Luis Querol, MD, PhD - CIDP at a Crossroads: Addressing the Burden of Suboptimal Care and the Need for Therapeutic Advancement [Listen](https://peervoice.com/140202711RZR.m4v?ProjectNumber=140202711&Promocode=862&AudienceID=PV) ## [Amarnath Challapalli, MBBS, MD (RT), MRCP, FRCR, PhD, FRCP / Amer Durrani, FRCS (Plast) - Partnering With Patients in High-Risk CSCC: Redefining the Surgical Paradigm to Optimise Clinical and Patient Outcomes](https://peervoice.com/KGV860) _2026-08-14 · PeerVoice Clinical Pharmacology Video_ Amarnath Challapalli, MBBS, MD (RT), MRCP, FRCR, PhD, FRCP / Amer Durrani, FRCS (Plast) - Partnering With Patients in High-Risk CSCC: Redefining the Surgical Paradigm to Optimise Clinical and Patient Outcomes [Listen](https://peervoice.com/540200037KGV.m4v?ProjectNumber=540200037&Promocode=862&AudienceID=PV) ## [Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Microlearning Activity 1: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium](https://videopodcast.researchtopractice.com/non-muscle-invasive-and-muscle-invasive-bladder-cancer-microlearning-activity-1-proceedings-from-a-session-held-adjunct-to-the-2026-asco-gu-cancers-symposium) _2026-08-14 · Research To Practice | Oncology Videos_ Featuring perspectives from Dr Terence Friedlander, Dr Matthew Galsky, Dr Shilpa Gupta and Prof Andrea Necchi, moderated by Dr Friedlander, including the following topics: Case: A healthy man in his early 70s who received several different lines of therapy for non-muscle-invasive bladder cancer (NMIBC), wants to avoid radical cystectomy and does not want pembrolizumab (0:00) Case: A man in his… [Listen](https://traffic.libsyn.com/secure/researchtopractice/ASCO_GU_Bladder_2-26-26_ML_V3FC_Issue_1_480.mp4?dest-id=1103750) ## Market Journal 1244 _2026-08-14 · Market Journal_ Importance of a Manure Test, Expanding Markets For Ethanol, Grain Markets, Weather, Soybean Gall Midge [Listen](http://s3-us-west-2.amazonaws.com/marketjournal/mjv-081426.mp4) ## [Dissecting Series A Rounds (Sponsored)](https://crawlproof.com/a/tAAuzc0ygprH) _2026-08-14 · **Sponsored**_ Two real Series A cases: timelines, investor sequencing, and common founder mistakes. ## [Non-Hodgkin Lymphoma — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting on the Roles of CAR T-Cell Therapy and Bispecific Antibodies](https://videopodcast.researchtopractice.com/non-hodgkin-lymphoma-proceedings-from-a-session-held-in-conjunction-with-the-2026-asco-annual-meeting-on-the-roles-of-car-t-cell-therapy-and-bispecific-antibodies) _2026-08-13 · Research To Practice | Oncology Videos_ Featuring perspectives from Dr Jeremy S Abramson, Dr Joshua Brody, Dr Manali Kamdar, Dr Tycel Phillips and Dr Jason Westin, moderated by Dr Abramson, including the following topics: Introduction (0:00) Chimeric Antigen Receptor (CAR) T-Cell Therapy for Diffuse Large B-Cell Lymphoma (DLBCL) — Dr Kamdar (2:16) Bispecific Antibody Therapy for DLBCL — Dr Westin (27:21) CAR T-Cell Therapy for Other… [Listen](https://traffic.libsyn.com/secure/researchtopractice/10_ASCO_CAR-T_5-31-26_V1_480.mp4?dest-id=1103750) ## [Prostate Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting](https://videopodcast.researchtopractice.com/prostate-cancer-proceedings-from-a-session-held-in-conjunction-with-the-2026-asco-annual-meeting) _2026-08-12 · Research To Practice | Oncology Videos_ Featuring perspectives from Dr Wassim Abida, Dr Rahul Aggarwal, Dr Emmanuel S Antonarakis, Prof Karim Fizazi and Dr Rana R McKay, moderated by Dr McKay, including the following topics: Introduction (0:00) Evolving Management of Nonmetastatic Hormone-Sensitive Prostate Cancer (HSPC) — Dr Antonarakis (2:42) Current and Future Hormonal Treatment for Metastatic HSPC (mHSPC) — Dr Aggarwal (26:23)… [Listen](https://traffic.libsyn.com/secure/researchtopractice/6_ASCO_Prostate_5-30-26_V1_480.mp4?dest-id=1103750) ## [How He Bootstrapped Dental Software to $16m](https://nathanlatkathetop.libsyn.com/how-he-bootstrapped-dental-software-to-16m) _2026-08-11 · Top Founders_ He bootstrapped to $16.5m ARR selling software to 2,000 dental offices. Zero dollars raised, 24% EBITDA, and $1.5m in free cash flow last year. COVID cut him back to $2m in 2021; he's added $14.5m since, charging $13k per dental office per year. When I asked what happens if Henry Schein shows up with $180m cash, he gave a surprising answer. [Listen](https://podtrac.com/pts/redirect.mp3/traffic.libsyn.com/secure/nathanlatkathetop/Practice_Numbers_V2.mp4?dest-id=284781) ## [Meletios Dimopoulos, MD - Individualisation Requires Communication: Working With Our Patients With Newly Diagnosed Multiple Myeloma (NDMM) to Optimise Treatment Outcomes](https://peervoice.com/PMG860) _2026-08-07 · PeerVoice Oncology & Haematology Video_ Meletios Dimopoulos, MD - Individualisation Requires Communication: Working With Our Patients With Newly Diagnosed Multiple Myeloma (NDMM) to Optimise Treatment Outcomes [Listen](https://peervoice.com/505205745-2PMG.m4v?ProjectNumber=505205745-2&Promocode=862&AudienceID=PV) ## Market Journal 1243 _2026-08-07 · Market Journal_ Southern Rust, Sunflowers for Soil Health, Grain Markets, Weather, Crop Disease Update [Listen](http://s3-us-west-2.amazonaws.com/marketjournal/mjv-080726.mp4) ## [Sicherheit für SAP: Umgang mit SAP-spezifischen Schwachstellen und Risiken](https://www.all-about-security.de/podcast/sicherheit-fuer-sap-umgang-mit-sap-spezifischen-schwachstellen-und-risiken/) _2026-08-02 · Unter4Ohren_ Sicherheit für SAP: Umgang mit SAP-spezifischen Schwachstellen und Risiken [Listen](https://www.all-about-security.de/podlove/file/6572/s/feed/c/mp4/sicherheit-fuer-sap-umgang-mit-sap-spezifischen-schwachstellen-und-risiken.mp4) ## Market Journal 1242 _2026-07-31 · Market Journal_ North American Manure Expo, Field Update, GovernorPillen's Trade Mission, Livestock Markets, Weather, UNL's AWESM Labs [Listen](http://s3-us-west-2.amazonaws.com/marketjournal/mjv-073126.mp4) ## Market Journal 1241 _2026-07-24 · Market Journal_ National High School Finals Rodeo, Field Update, Crop Markets, Weather, ALA Engineering Field Day, Gudmundsen Sandhills Laboratory Open House [Listen](http://s3-us-west-2.amazonaws.com/marketjournal/mjv-072426.mp4) ## [How David Chevalier Hit $15M ARR With a Chrome Extension and No Sales Team - Surfe](https://nathanlatkathetop.libsyn.com/how-david-chevalier-hit-15m-arr-with-a-chrome-extension-and-no-sales-team-surfe) _2026-07-23 · Top Founders_ How do you go from a Chrome extension with no sales team to $15M in revenue in five years, while raising less money than most startups spend in their first year? David Chevalier is the co-founder and CEO of Surfe, the leading CRM enrichment and waterfall data platform for B2B sales teams. He bootstrapped for two years, grew to $1.5M purely through HubSpot and Pipedrive marketplace rankings, and… [Listen](https://podtrac.com/pts/redirect.mp3/traffic.libsyn.com/secure/nathanlatkathetop/surfe-chevalier-revenue-10m-raised-15m-arr-2026.mp4?dest-id=284781) ## [Schatten-KI im Unternehmen: Wie der Enterprise Browser Kontrolle zurückbringt](https://www.all-about-security.de/podcast/schatten-ki-im-unternehmen-wie-der-enterprise-browser-kontrolle-zurueckbringt/) _2026-07-22 · Unter4Ohren_ Schatten-KI im Unternehmen: Wie der Enterprise Browser Kontrolle zurückbringt [Listen](https://www.all-about-security.de/podlove/file/6557/s/feed/c/mp4/schatten-ki-im-unternehmen-wie-der-enterprise-browser-kontrolle-zurueckbringt.mp4) ## [Retro Grid Dungeon Crawler (Sponsored)](https://crawlproof.com/a/NPJbBSEnyLC2) _2026-07-22 · **Sponsored**_ Retro grid movement with first-person combat, loot and skill-tree progression. ## [One Disease, Many Clinical Presentations: Why and How to Spot Acute Hepatic Porphyria in Different Healthcare Settings](https://peervoice.com/GVP860) _2026-07-20 · PeerVoice Brain & Behaviour Video_ One Disease, Many Clinical Presentations: Why and How to Spot Acute Hepatic Porphyria in Different Healthcare Settings [Listen](https://peervoice.com/140202724GVP.m4v?ProjectNumber=140202724&Promocode=862&AudienceID=PV) ## [John Friedewald, MD, FASN, FAST - Breakthroughs and Buzz From Boston: Key Takeaways for the Kidney Transplant Community](https://peervoice.com/WBP860) _2026-07-20 · PeerVoice Clinical Pharmacology Video_ John Friedewald, MD, FASN, FAST - Breakthroughs and Buzz From Boston: Key Takeaways for the Kidney Transplant Community [Listen](https://peervoice.com/140202770WBP.m4v?ProjectNumber=140202770&Promocode=862&AudienceID=PV) ## [Kausik Ray, MD, MPhil (Cantab), FMedSci - Altering the Disease Trajectory in Patients With and at High Risk of Atherosclerotic Cardiovascular Disease: Ensuring Best Practices for Identification and Management](https://peervoice.com/VUR860) _2026-07-20 · PeerVoice Clinical Pharmacology Video_ Kausik Ray, MD, MPhil (Cantab), FMedSci - Altering the Disease Trajectory in Patients With and at High Risk of Atherosclerotic Cardiovascular Disease: Ensuring Best Practices for Identification and Management [Listen](https://peervoice.com/140202828VUR.m4v?ProjectNumber=140202828&Promocode=862&AudienceID=PV) ## Market Journal 1240 _2026-07-17 · Market Journal_ Recovery Status in The Sandhills, Skilled Ag Workers, Beef Markets, Weather, Soil Health Training [Listen](http://s3-us-west-2.amazonaws.com/marketjournal/mjv-071726.mp4) ## [Practice by Numbers: $16.5M Dental SaaS, 24% EBITDA, Zero VC - Rohit Garg](https://nathanlatkathetop.libsyn.com/practice-by-numbers-165m-dental-saas-24-ebitda-zero-vc-rohit-garg) _2026-07-16 · Top Founders_ How do you build a $16.5M vertical SaaS company with 24% EBITDA margins with zero paid acquisition, zero outside funding, and your wife as co-founder? Rohit Garg is the co-founder and CEO of Practice by Numbers, an all-in-one dental practice management platform serving 1,300 customers across 2,000 locations. He started building it in 2015 because his wife is a dentist and he was the one running… [Listen](https://podtrac.com/pts/redirect.mp3/traffic.libsyn.com/secure/nathanlatkathetop/practicebynumbers-garg-revenue-16m-dental-saas-2026.mp4?dest-id=284781) ## Market Journal 1239 _2026-07-10 · Market Journal_ Nebraska Nitrogen Initiative, Commercial Beekeeping, Grain Markets, Weather, NASA's Acres Farm Innovation Ambassador Program [Listen](http://s3-us-west-2.amazonaws.com/marketjournal/mjv-071026.mp4) ## [Handwrytten Sends 6 Million Fake Handwritten Notes a Year and Makes $10M](https://nathanlatkathetop.libsyn.com/handwrytten-sends-6-million-fake-handwritten-notes-a-year-and-makes-10m) _2026-07-10 · Top Founders_ How do you build a $10M business by teaching robots to write handwritten notes with real pens, and do it with zero outside investment for 12 straight years? David Wachs sold his text message marketing company for eight figures in 2012, started Handwrytten the next day, and has bootstrapped it to 200 custom-built robots in a Phoenix facility sending 350,000 notes per month. He owns 100% of the… [Listen](https://podtrac.com/pts/redirect.mp3/traffic.libsyn.com/secure/nathanlatkathetop/handwrytten-wachs-revenue-10m-robot-notes-2026.mp4?dest-id=284781) ## Market Journal 1238 _2026-07-03 · Market Journal_ Host Bryce Doeschot breaks down the biggest challenges facing family-owned farms with a panel of experts. [Listen](http://s3-us-west-2.amazonaws.com/marketjournal/mjv-070326.mp4) ## [Featherless: $3.6M Revenue Running 6,700 Open Source AI Models — Eugene Cheah](https://nathanlatkathetop.libsyn.com/featherless-36m-revenue-running-6700-open-source-ai-models-eugene-cheah) _2026-07-01 · Top Founders_ How do you go from a pricing experiment inside a failing product to $3.6 million in annual revenue with 10,000 customers — in under two years and with zero paid marketing? Eugene Cheah is the co-founder and CEO of Featherless.ai, the largest open source LLM inference provider on Hugging Face. He co-created RWKV, the first attention-free AI architecture under the Linux Foundation, and today runs a… [Listen](https://podtrac.com/pts/redirect.mp3/traffic.libsyn.com/secure/nathanlatkathetop/featherless-cheah-4m-revenue-open-source-llm-saas-2026.mp4?dest-id=284781) ## [Carel le Roux, MBChB, MSc, PhD - Beyond BMI: Transforming Modern Weight Management for Heart, Kidney, and Metabolic Health](https://peervoice.com/VAC860) _2026-06-29 · PeerVoice Endocrinology & Metabolic Disorders Video_ Carel le Roux, MBChB, MSc, PhD - Beyond BMI: Transforming Modern Weight Management for Heart, Kidney, and Metabolic Health [Listen](https://peervoice.com/140202789-2VAC.m4v?ProjectNumber=140202789-2&Promocode=862&AudienceID=PV) ## Market Journal 1237 _2026-06-26 · Market Journal_ Hail Damaged Crops, Western Bean Cutworm Research, Grain Markets, Weather, Weed Management Field Daysq [Listen](http://s3-us-west-2.amazonaws.com/marketjournal/mjv-062626.mp4) ## Market Journal 1236 _2026-06-19 · Market Journal_ Small Town Manufacturing, Tar Spot, Summer Grazing, Cattle Markets, Weather, Wildlife Updates [Listen](http://s3-us-west-2.amazonaws.com/marketjournal/mjv-061926.mp4) ## [Gather AI: $15M Revenue With Drones and 170% Net Retention - Sankalp Arora](https://nathanlatkathetop.libsyn.com/gather-ai-15m-revenue-with-drones-and-170-net-retention-sankalp-arora) _2026-06-17 · Top Founders_ How do you build a $15M revenue business by teaching autonomous drones to find missing sneakers in warehouses , and get customers to more than double their spend every single year? Sankalp Arora is the founder and CEO of Gather AI, a physical AI company that uses autonomous drones and computer vision to track inventory in real time across warehouses. He holds a PhD in robotics from Carnegie… [Listen](https://podtrac.com/pts/redirect.mp3/traffic.libsyn.com/secure/nathanlatkathetop/gather-ai-arora-revenue-drone-warehouse-ep.mp3?dest-id=284781) ## Market Journal 1235 _2026-06-12 · Market Journal_ Hail Damaged Corn, Grain Markets, Weather, Agricultural Data, Weed Management Field Day [Listen](http://s3-us-west-2.amazonaws.com/marketjournal/mjv-061226.mp4) ## [Tive Hit $100M Revenue After a Down Round and $10K in the Bank](https://nathanlatkathetop.libsyn.com/tive-hit-100m-revenue-after-a-down-round-and-10k-in-the-bank) _2026-06-11 · Top Founders_ How do you go from $10,000 left in the bank and a down round to $100 million in annual revenue — without ever seriously considering quitting? Krenar Komoni is the founder and CEO of Tive, a hardware-plus-SaaS company that tracks shipments in real time across trucks, ships, and planes worldwide. He started in his basement in 2015, charging his father-in-law $19.99 a month, and today has 1,300… [Listen](https://podtrac.com/pts/redirect.mp3/traffic.libsyn.com/secure/nathanlatkathetop/tive-komoni-revenue-100m-supply-chain-ep.mp3?dest-id=284781) ## [Hannele Yki-Järvinen, MD, FRCP - MASH Matters – and It’s More Than Just a Metabolic Disease](https://peervoice.com/YWG860) _2026-06-09 · PeerVoice Endocrinology & Metabolic Disorders Video_ Hannele Yki-Järvinen, MD, FRCP - MASH Matters – and It’s More Than Just a Metabolic Disease [Listen](https://peervoice.com/540200065YWG.m4v?ProjectNumber=540200065&Promocode=862&AudienceID=PV) ## [Andrea Necchi, MD - Working With Our Patients as a Member of the MDT: A Bladder Cancer Awareness Month 2026 CME Initiative](https://peervoice.com/QZY860) _2026-06-09 · PeerVoice Oncology & Haematology Video_ Andrea Necchi, MD - Working With Our Patients as a Member of the MDT: A Bladder Cancer Awareness Month 2026 CME Initiative [Listen](https://peervoice.com/140202878QZY.m4v?ProjectNumber=140202878&Promocode=862&AudienceID=PV) ## [David Alain Wohl, MD - From Guidelines to Ground Truth: The Reality of Rapid ART in the Real World](https://peervoice.com/DMZ860) _2026-06-05 · PeerVoice Clinical Pharmacology Video_ David Alain Wohl, MD - From Guidelines to Ground Truth: The Reality of Rapid ART in the Real World [Listen](https://peervoice.com/140202709DMZ.m4v?ProjectNumber=140202709&Promocode=862&AudienceID=PV) ## [Silvia Stacchiotti, MD / Michiel van de Sande, MD, PhD - Surgical Interventions and Systemic Innovations: Collaborative Approaches to Tenosynovial Giant Cell Tumour as Pharmacological Advances Emerge](https://peervoice.com/TPE860) _2026-06-05 · PeerVoice Clinical Pharmacology Video_ Silvia Stacchiotti, MD / Michiel van de Sande, MD, PhD - Surgical Interventions and Systemic Innovations: Collaborative Approaches to Tenosynovial Giant Cell Tumour as Pharmacological Advances Emerge [Listen](https://peervoice.com/540200066TPE.m4v?ProjectNumber=540200066&Promocode=862&AudienceID=PV) ## [Javier Cortés, MD, PhD / Laura Huppert, MD - Novel Uses for Trusted Tools: Investigational Approaches for TROP2-Directed ADCs in Advanced Breast Cancer](https://peervoice.com/CFH860) _2026-06-05 · PeerVoice Clinical Pharmacology Video_ Javier Cortés, MD, PhD / Laura Huppert, MD - Novel Uses for Trusted Tools: Investigational Approaches for TROP2-Directed ADCs in Advanced Breast Cancer [Listen](https://peervoice.com/140202671CFH.m4v?ProjectNumber=140202671&Promocode=862&AudienceID=PV)